DXR
Daxor CorporationNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$58.97M
P/E Ratio
6.36
EPS
$1.59
Beta
0.29
52W High
$14.76
52W Low
$7.13
50-Day MA
$10.57
200-Day MA
$11.87
Dividend Yield
—
Profit Margin
34359.00%
Forward P/E
64.52
PEG Ratio
0.00
About Daxor Corporation
Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 26,690 |
| Gross Profit (TTM) | 26,690 |
| EBITDA | — |
| Operating Margin | -9661.00% |
| Return on Equity | 22.50% |
| Return on Assets | -1.64% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $9.07 |
| Price-to-Book | 1.33 |
| Price-to-Sales (TTM) | 2209.66 |
| EV/Revenue | 5.9 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 329.30% |
| Quarterly Revenue Growth (YoY) | -82.60% |
| Shares Outstanding | $5.83M |
| Float | $2.57M |
| % Insiders | 49.02% |
| % Institutions | 1.45% |
Historical Volatility
HV 10-Day
74.94%
HV 20-Day
55.88%
HV 30-Day
54.40%
HV 60-Day
41.74%
HV Rank
73.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($22.50 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026